Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,008.00
0.00 (0.00%)
Oct 5, 2025, 3:52 PM IDT
Nissan Medical Industries Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 627.95 | 664.08 | 733.91 | 684.65 | 668.37 | 721.48 | Upgrade | |
Revenue Growth (YoY) | -13.86% | -9.52% | 7.20% | 2.44% | -7.36% | 19.16% | Upgrade |
Cost of Revenue | 556.46 | 566.06 | 598.14 | 601.37 | 523.95 | 540.03 | Upgrade |
Gross Profit | 71.49 | 98.02 | 135.78 | 83.28 | 144.42 | 181.45 | Upgrade |
Selling, General & Admin | 67.08 | 68.35 | 73.14 | 85.19 | 78.54 | 71.21 | Upgrade |
Other Operating Expenses | -0.01 | -0.01 | 1.26 | -0.15 | 0.07 | -0.1 | Upgrade |
Operating Expenses | 67.08 | 68.35 | 74.4 | 85.04 | 78.61 | 71.11 | Upgrade |
Operating Income | 4.42 | 29.68 | 61.37 | -1.77 | 65.81 | 110.34 | Upgrade |
Interest Expense | -13.24 | -13.34 | -21.27 | -10.02 | -7.28 | -9.39 | Upgrade |
Interest & Investment Income | 0.82 | 0.47 | 0.18 | 0.01 | - | 0.09 | Upgrade |
Earnings From Equity Investments | 1.05 | 1.3 | -7.06 | -0.64 | 4.62 | 10.66 | Upgrade |
Currency Exchange Gain (Loss) | 2.1 | 1.51 | 0.05 | -8.33 | 3.19 | -1.06 | Upgrade |
Other Non Operating Income (Expenses) | -5.41 | -4.46 | -5.47 | -2.44 | -1.28 | -1.3 | Upgrade |
EBT Excluding Unusual Items | -10.26 | 15.15 | 27.81 | -23.18 | 65.06 | 109.33 | Upgrade |
Impairment of Goodwill | - | - | - | -23.79 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 0 | 0 | 0.01 | -0.05 | 5.39 | 0.68 | Upgrade |
Pretax Income | -6.26 | 15.15 | 27.82 | -47.02 | 70.45 | 110.01 | Upgrade |
Income Tax Expense | -2.41 | 1.35 | 8.78 | 0.27 | 13.29 | 17.12 | Upgrade |
Earnings From Continuing Operations | -3.85 | 13.8 | 19.04 | -47.29 | 57.16 | 92.89 | Upgrade |
Minority Interest in Earnings | 1.22 | -5.9 | -13.39 | 11.24 | -21.14 | -36.04 | Upgrade |
Net Income | -2.63 | 7.91 | 5.65 | -36.05 | 36.01 | 56.85 | Upgrade |
Net Income to Common | -2.63 | 7.91 | 5.65 | -36.05 | 36.01 | 56.85 | Upgrade |
Net Income Growth | - | 39.95% | - | - | -36.65% | 261.87% | Upgrade |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade |
EPS (Basic) | -0.30 | 0.87 | 0.62 | -3.97 | 3.96 | 6.26 | Upgrade |
EPS (Diluted) | -0.30 | 0.87 | 0.62 | -3.97 | 3.93 | 6.26 | Upgrade |
EPS Growth | - | 39.90% | - | - | -37.13% | 261.87% | Upgrade |
Free Cash Flow | 25.19 | 20.74 | 95.9 | 2.49 | 9.82 | 108.71 | Upgrade |
Free Cash Flow Per Share | 2.89 | 2.28 | 10.56 | 0.28 | 1.08 | 11.97 | Upgrade |
Dividend Per Share | 2.570 | 2.570 | - | - | 0.440 | 1.000 | Upgrade |
Dividend Growth | - | - | - | - | -56.00% | - | Upgrade |
Gross Margin | 11.39% | 14.76% | 18.50% | 12.16% | 21.61% | 25.15% | Upgrade |
Operating Margin | 0.70% | 4.47% | 8.36% | -0.26% | 9.85% | 15.29% | Upgrade |
Profit Margin | -0.42% | 1.19% | 0.77% | -5.27% | 5.39% | 7.88% | Upgrade |
Free Cash Flow Margin | 4.01% | 3.12% | 13.07% | 0.36% | 1.47% | 15.07% | Upgrade |
EBITDA | 27.57 | 53 | 86.9 | 26.88 | 91.4 | 137.76 | Upgrade |
EBITDA Margin | 4.39% | 7.98% | 11.84% | 3.93% | 13.68% | 19.09% | Upgrade |
D&A For EBITDA | 23.15 | 23.32 | 25.52 | 28.65 | 25.6 | 27.42 | Upgrade |
EBIT | 4.42 | 29.68 | 61.37 | -1.77 | 65.81 | 110.34 | Upgrade |
EBIT Margin | 0.70% | 4.47% | 8.36% | -0.26% | 9.85% | 15.29% | Upgrade |
Effective Tax Rate | - | 8.92% | 31.56% | - | 18.87% | 15.56% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.